Abstract:Prostate cancer (PCa) is a common urinary malignancy. The lack of specific and sensitive biomarkers for the early diagnosis and prognosis of PCa makes it important to seek alternatives. R software was used to analyze the PCa expression profile from data sets in Gene Expression Omnibus. Core differential genes were identified by String and Cytoscape and further validated by Gene Expression Profiling Interactive Analysis (GEPIA) and The Human Protein Atlas (HPA). Gene Ontology analysis was done in the DIVID database and visualization analysis was conducted by Hiplot. Pathway enrichment was analyzed by IPA. To identify potential competitive endogenous RNAs (ceRNA) networks, the experimentally validated microRNA‐target interactions database (miRTarBase), The Encyclopedia of RNA Interactomes (StarBase), lncBase, and GEPIA were used. The lncLocator was utilized to perform subcellular localization of long noncoding RNAs (lncRNAs). Both miRTarBase and StarBase were used to find the binding site of mRNAs‐miRNAs and miRNAs‐lncRNAs. Visualization of the ceRNA network was performed with Cytoscape. Nine genes closely related to the diagnosis and prognosis of PCa were obtained, including four identified biomarkers by HPA, CENPF, TPX2, TK1, and CCNB1, and five novel PCa biomarkers, RRM2, UBE2C, TOP2A, BIRC5, and ZWINT. Pathway analysis indicated that PCa carcinogenesis was highly correlated with liver fibrosis pathways, ILK signaling, and NRF2‐mediated oxidative stress response. Two sets of ceRNA networks, BIRC5/hsa‐miR‐218‐5p/NEAT1 and UBE2C/hsa‐miR‐483‐3p/NEAT1 were found to be novel biomarkers for the identification of PCa. The quantitative real‐time polymerase chain reaction results verified that UBE2C, BIRC5, and NEAT1 were upregulated and hsa‐miR‐218‐5p and hsa‐miR‐483‐3p were downregulated in human PCa cells compared with normal prostate epithelial cells. The novel identified biomarkers in this study would be valuable for the diagnosis and prognosis of PCa.

Identification of a prostate-specific G-protein coupled receptor in prostate cancer

GPRC5A: an Emerging Biomarker in Human Cancer

Overexpression of G Protein-Coupled Receptors in Cancer Cells: Involvement in Tumor Progression.

Identification Of Prostate-Specific G-Protein Coupled Receptor As A Tumor Antigen Recognized By Cd8(+) T Cells For Cancer Immunotherapy

Recognition of Invasive Prostate Cancer Using a GHRL Polypeptide Probe Targeting GHSR in a Mouse Model <i>In vivo</i>

Prostate-Localized and Androgen-Regulated Expression of the Membrane-Bound Serine Protease Tmprss2

Regulation of human prostate-specific G-protein coupled receptor, PSGR, by two distinct promoters and growth factors.

Prostate Carcinoma Tissue Proteomics for Biomarker Discovery.

Primary functional identification of gene TMSG-1

Advances in Brief Prostate-localized and Androgen-regulated Expression of the Membrane-bound Serine Protease TMPRSS 2 1

Ectonucleotidases and Purinergic Receptors in Mouse Prostate Gland

Gpr39, A Putative Receptor Of Zn2+, Is Region Specifically Localized In Different Lobes Of The Mouse Prostate

Identification of novel biomarkers in prostate cancer diagnosis and prognosis

The Identification of Potential Biomarkers and Biological Pathways in Prostate Cancer.

G-protein-coupled receptor 137 accelerates proliferation of urinary bladder cancer cells in vitro.

Identifying differentially expressed genes and small molecule drugs for prostate cancer by a bioinformatics strategy

Part-1: A Novel Human Prostate-Specific, Androgen-Regulated Gene That Maps To Chromosome 5q12

Large set data mining reveals overexpressed GPCRs in prostate and breast cancer: potential for active targeting with engineered anti-cancer nanomedicines

Prostate Short-Chain Dehydrogenase Reductase 1 (PSDR1): a New Member of the Short-Chain Steroid Dehydrogenase/reductase Family Highly Expressed in Normal and Neoplastic Prostate Epithelium.

[Expression of prostate stem cell antigen (PSCA) and selection of its specific binding peptide]

The Program of Androgen-Responsive Genes in Neoplastic Prostate Epithelium.